Ovid Therapeutics Hosts Educational Webinar on Angelman Syndrome and OV101 Development Program Oct 22, 2020 1:00 PM EDT Click here for webcast
Press Releases Year None202020192018201720162015 Oct 14, 2020 Ovid Therapeutics to Host Educational Webinar on Angelman Syndrome and OV101 Development Program Oct 12, 2020 Ovid Therapeutics to Present at the Child Neurology Society/International Child Neurology Association (CNS/ICNA) Virtual Congress Sep 30, 2020 Ovid Therapeutics Provides Soticlestat (OV935/TAK-935) Results from ARCADE and ENDYMION Studies Showing Seizure Reduction in Rare Epilepsies Sep 11, 2020 Ovid Therapeutics to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference Aug 25, 2020 Ovid Therapeutics Announces Pricing of $50 Million Offering of Common Stock Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page next › Last page last »
